Welcome

Warp Speed Lessons to Cut Clinical Trial Paperwork: Woodcock

April 9, 2021, 7:43 PM

Physicians running clinical trials may have less paperwork in the future by relying more on electronic health records and telemedicine, acting FDA Commissioner Janet Woodcock said.

Woodcock, who stepped away from her role as the Food and Drug Administration’s longtime drug chief last year to work on Operation Warp Speed, said Friday the therapeutics group she headed under Warp Speed is compiling a list of lessons learned with opportunities to streamline future clinical trials.

“It’s going to be a long list,” she said. “We were really impeded—and we still are—by too much trial bureaucracy and unnecessary repetition of all kinds ...

To read the full article log in.

Learn more about A Bloomberg Law subscription.